New Brunswick is reporting the death of a person in their 50s who passed away due to blood clot complications after getting the AstraZenca vaccine.
According to the province, the person received the AstraZeneca vaccine in mid-April, and developed symptoms 17 days later. They went to an emergency room for treatment and were hospitalized.
Dr. Jennifer Russell, chief medical officer of health, said that the use of the AstraZeneca vaccine will not be changed. It will still be used in limited circumstances for first doses and second doses, Russell said at a COVID-19 briefing Friday.
On May, 5, a person in their 60s has died after experiencing blood clots and low platelets after getting the Oxford-AstraZeneca vaccine.
There are 3,500 doses left and they expire on May 31. Those who got AstraZeneca for their first dose eight weeks ago can now get second doses.
“Because we know some people prefer it to one of the mRNA vaccines, we want to provide (AstraZeneca) as an option,” Russell said.
“For those who received the first dose of AstraZeneca, but do not want AstraZeneca as a second dose, we expect to receive direction from the federal government soon on using another brand of vaccine as a booster,” she added.
